Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma.
Sulis
E
E
Floris
C
C
Sulis
M L
ML
Zurrida
S
S
Piro
S
S
Pintus
A
A
Contu
L
L
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D009062:Mouth Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*; D019966:Substance-Related Disorders
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins